Skip to content

Äkillisen akustisen vamman hoito ylipaineisella happihoidolla ja lääkkeillä: Prospektiivinen satunnaistettu ja kontrolloitu tutkimus vamman saaneilla varusmiehillä. - Akustisen vamman hoito

Äkillisen akustisen vamman hoito ylipaineisella happihoidolla ja lääkkeillä: Prospektiivinen satunnaistettu ja kontrolloitu tutkimus vamman saaneilla varusmiehillä. - Akustisen vamman hoito

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2008-000444-13-FI
Enrollment
240
Registered
2008-03-11
Start date
2008-04-08
Completion date
Unknown
Last updated
2014-11-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acustic or barotraumas after gun accident in conscripts MedDRA version: 9.1 Level: LLT Classification code 10061688 Term: Barotrauma

Interventions

Pharmaceutical Form: Tablet INN or Proposed INN: BETAHISTINE CAS Number: 5638766 Pharmaceutical Form: Tablet INN or Proposed INN: METHYLPREDNISOLONE CAS Number: 83432

Sponsors

Finnish Defence Forces
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Severe enough acustic or barotraumas and/or tinnitus Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Mild traumas which are cured within a day spontaneusly

Design outcomes

Primary

MeasureTime frame
Main Objective: Does medical treatment with methylprednisone and betahistidine hydrochloride have an effect on patients treated with HBO;Secondary Objective: ;Primary end point(s): Audiometric investigation 2 months after the trauma/treatment

Countries

Finland

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026